These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 37686119)

  • 1. Challenges and Future Trends in the Treatment of Psoriasis.
    Lee HJ; Kim M
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging trends in combination strategies with phototherapy in advanced psoriasis management.
    Sreya R; Nene S; Pathade V; Singh SB; Srivastava S
    Inflammopharmacology; 2023 Aug; 31(4):1761-1778. PubMed ID: 37326755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review.
    Armstrong AW; Read C
    JAMA; 2020 May; 323(19):1945-1960. PubMed ID: 32427307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Topical Psoriasis Treatment to Enhance Systemic and Phototherapy: A Review of the Literature.
    Bagel J; Gold LS
    J Drugs Dermatol; 2017 Dec; 16(12):1209-1222. PubMed ID: 29240856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current challenges and emerging drug delivery strategies for the treatment of psoriasis.
    Hoffman MB; Hill D; Feldman SR
    Expert Opin Drug Deliv; 2016 Oct; 13(10):1461-73. PubMed ID: 27164301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
    Busard CI; Cohen AD; Wolf P; Gkalpakiotis S; Cazzaniga S; Stern RS; Hutten BA; Feldhamer I; Quehenberger F; Lichem R; Kojanova M; Adenubiova E; Addis A; Naldi L; Spuls PI
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):245-253. PubMed ID: 28898541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of biologic agents in combination with other therapies for the treatment of psoriasis.
    Cather JC; Crowley JJ
    Am J Clin Dermatol; 2014 Dec; 15(6):467-78. PubMed ID: 25373522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapy with or without topical treatment in psoriasis: what does the current evidence say?
    Jensen JD; Delcambre MR; Nguyen G; Sami N
    Am J Clin Dermatol; 2014 Oct; 15(5):379-85. PubMed ID: 25027461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging landscape in psoriasis management: From topical application to targeting biomolecules.
    Rapalli VK; Singhvi G; Dubey SK; Gupta G; Chellappan DK; Dua K
    Biomed Pharmacother; 2018 Oct; 106():707-713. PubMed ID: 29990862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real-life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists.
    Mahé E; Beauchet A; Hadj-Rabia S; Mazereeuw-Hautier J; Mallet S; Phan A; Severino-Freire M; Boralevi F; Aubert H; Barthélémy H; Girard C; Martin L; Piram M; Barbarot S; Balguerie X; Zitouni J; Phan C; Di Lernia V;
    Dermatol Ther; 2022 Nov; 35(11):e15828. PubMed ID: 36107157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing patient copayment levels for topical and systemic treatments in plaque psoriasis as a case for evidence-based, sustainable pharmaceutical policy change in Greece.
    Souliotis K; Golna C; Kani C; Litsa P
    J Med Econ; 2016 Nov; 19(11):1021-1026. PubMed ID: 27207488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Navigating the landscape of psoriasis therapy: novel targeted pathways and emerging trends.
    Innani S; Tomar Y; Rana V; Singhvi G
    Expert Opin Ther Targets; 2023; 27(12):1247-1256. PubMed ID: 37997278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolving Landscape of Psoriasis Treatment.
    Armstrong AW; Gordon KB; Menter MA; Wu JJ
    Semin Cutan Med Surg; 2018 Feb; 37(2S):S39-S43. PubMed ID: 29614136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phototherapy, psoriasis, and the age of biologics.
    Richard EG; Hönigsmann H
    Photodermatol Photoimmunol Photomed; 2014 Feb; 30(1):3-7. PubMed ID: 24313462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging systemic drugs in the treatment of plaque psoriasis.
    Balogh EA; Bashyam AM; Ghamrawi RI; Feldman SR
    Expert Opin Emerg Drugs; 2020 Jun; 25(2):89-100. PubMed ID: 32192366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging systemic treatment strategies for psoriasis.
    Laws PM; Young HS
    Drugs; 2012 Oct; 72(14):1867-80. PubMed ID: 22938141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancements in the treatment of psoriasis: role of biologic agents.
    Rich SJ; Bello-Quintero CE
    J Manag Care Pharm; 2004; 10(4):318-25. PubMed ID: 15298530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
    Price J; Bhosle M; Feldman SR; Balkrishnan R
    J Drugs Dermatol; 2007 Mar; 6(3):259-67. PubMed ID: 17373187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plaque-type psoriasis inhibitors.
    Shobeiri SS; Khorrami M; Sankian M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108326. PubMed ID: 34782274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.